Out of 123 vaccines, seven are ready for human trials


Sorrento Therapeutics (SRNE), an American biotech company, reported that they have a cure for the coronavirus disease, another biotech also said it had achieved a thumbs up for a new method of coronavirus tests; on the same day, the CBS news channel also reported that the NIH has confirmed that the researchers have begun testing a coronavirus vaccine.

Henry Ji, SRNE Chief Executive, told Fox News the antibody drug they have produced could provide “100 percent inhibition” of Covid-19. “We want to emphasise there is a cure,” he said. “If we have the neutralising antibody in your body, you don’t need the social distancing.” 

But according to the Milken Institute, a US think tank that is monitoring the research works, urged. “Some 200 therapeutics are being developed as possible treatments for Covid-19; and a remarkable 123 vaccines are under development to prevent infections,”

Of them, seven have entered the stage of human trials; Moderna’s vaccine was the first in the United States, six other vaccine candidates are from the Beijing Institute of Biological Products, CanSino Biologics (Ad5-nCoV), BioNTech (BNT162), Inovio Pharmaceuticals (INO-4800), University of Oxford (ChAdOx1 nCoV-19) and Sinovac Biotech.

The Wall Street Journal reported that a dozen of America’s top scientists, industry titans, and financiers had formed a group known as “Scientists to Stop Covid-19” — to find a cure for this disease.

They have also pledged not to make a profit from this and to sell whatever shares they might have in their companies; one member who refused was asked to leave.


Please enter your comment!
Please enter your name here